ADCC Mediated B-Cell dEpletion and BAFF-R Blockade (AMBER)
Study description
VAY736 dose testing; VAY736 efficacy and safety testing.
Pathology
Autoimmune Hepatitis
Study type
Clinical trial
Status
Active
Study start date
2017
Funder Type
Industry funded study
Investigator
Dr.ssa med. Benedetta TERZIROLI BERETTA-PICCOLI
Recruitment
Recruiting
For information, please contact the Foundation